Lewis H Titterton jr bought $26k of ANIX
director at Anixa Biosciences Inc. 10,000 shares at an average of $2.57, traded Jan 17, 2025, filed Jan 17, 2025.
Score components
- +15RoleDirector
- +5Trade size$26k at market
- 0Relative to holdingsHoldings up 1.1%
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +30.3%, 3m +12.9%, 6m +42.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-25-002717, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | POpen-market purchase Common Stock | +10,000 | $2.57 | $26k | 922,334 | Jan 17, 2025 |
Related signals
Other insiders at Anixa Biosciences Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | Anixa Biosciences Inc | Michael Catelani President, COO, & CFO | $16k 5,500 shares | +12% | |
| 30Weak | Anixa Biosciences Inc | Arnold M Baskies director | $14k 5,000 shares | +4% | |
| 45Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $19k 7,000 shares | +1% | |
| 46Moderate | Anixa Biosciences Inc | Lewis H Titterton jr director | $132k 49,036 shares | +5% | |
| 35Weak | Anixa Biosciences Inc | Lewis H Titterton jr director | $27k 10,000 shares | +1% | |
| 35Weak | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $8,250 3,000 shares | +0% | |
| 35Weak | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $14k 5,000 shares | +1% | |
| 51Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $17k 5,000 shares | +1% | |
| 51Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $17k 5,000 shares | +1% | |
| 47Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $11k 3,000 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.